Voyageur Pharmaceuticals Ltd. (VM.V)
CAD 0.11
(50.0%)
CAD 0.11
(50.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -991.25 Thousand | -1.71 Million | -1.65 Million | -272.19 Thousand | -637.8 Thousand | -490.45 Thousand |
| Net Income | -1.39 Million | -1.75 Million | -2.05 Million | -1.13 Million | -552.29 Thousand | -555.86 Thousand |
| Depreciation & Amortization | 2185.00 | 9210.00 | 2246.00 | 1483.00 | 2120.00 | - |
| Deferred income taxes | -250.44 Thousand | 6210.00 | - | 152.1 Thousand | -2600.00 | -26.87 Thousand |
| Stock-based compensation | 234.02 Thousand | 207.29 Thousand | 737.6 Thousand | 279.25 Thousand | 5315.00 | 295.05 Thousand |
| Change in working capital | 110.15 Thousand | -243.72 Thousand | -342.66 Thousand | 438.11 Thousand | -90.34 Thousand | 80.52 Thousand |
| Other non-cash items | 312.3 Thousand | 56.15 Thousand | -1.00 | -3725.00 | -110.29 Thousand | -283.29 Thousand |
| Investing Cash Flow | -174.72 Thousand | -274.15 Thousand | -432.07 Thousand | -151.79 Thousand | -169.61 Thousand | -224.05 Thousand |
| Investments in PPE | -174.72 Thousand | -282.91 Thousand | -432.07 Thousand | -161.93 Thousand | -1829.00 | -320.99 Thousand |
| Acquisitions | - | 8763.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -174.72 Thousand | -282.91 Thousand | -438.05 Thousand | 10.14 Thousand | -167.78 Thousand | 96.94 Thousand |
| Financing Cash Flow | 1.13 Million | 1.21 Million | 2.89 Million | 351.33 Thousand | 736.12 Thousand | 844.37 Thousand |
| Debt repayment | - | -16.55 Thousand | -18.85 Thousand | -3732.00 | -8584.00 | -8129.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.13 Million | 1.15 Million | 2.3 Million | 154.7 Thousand | 793.24 Thousand | 909.81 Thousand |
| Other Financing Activities | -63.45 Thousand | 71.05 Thousand | 610.14 Thousand | 200.37 Thousand | -48.53 Thousand | -57.3 Thousand |
| Accounts receivables | -12.05 Thousand | 17.65 Thousand | -28.87 Thousand | 1500.00 | -16.83 Thousand | 1350.00 |
| Accounts payables | - | -192.45 Thousand | -81.87 Thousand | 165.8 Thousand | 146.79 Thousand | 20.12 Thousand |
| Inventory | - | -610.00 | 168.00 | 232.00 | -10.11 Thousand | 90.27 Thousand |
| Other working capital | 122.2 Thousand | -68.3 Thousand | -232.07 Thousand | 270.58 Thousand | -210.19 Thousand | -31.22 Thousand |
| Cash at beginning of period | 31.56 Thousand | 812.96 Thousand | 2967.00 | 75.61 Thousand | 146.91 Thousand | 17.04 Thousand |
| Cash at end of period | 2085.00 | 31.56 Thousand | 812.96 Thousand | 2967.00 | 75.61 Thousand | 146.91 Thousand |
| Capital Expenditure | -174.72 Thousand | -282.91 Thousand | -432.07 Thousand | -161.93 Thousand | -1829.00 | -320.99 Thousand |
| Effect of forex changes on cash | - | - | 1.00 | - | - | - |
| Net cash flow / Change in cash | -29.47 Thousand | -781.4 Thousand | 810 Thousand | -72.64 Thousand | -71.3 Thousand | 129.86 Thousand |
| Free Cash Flow | -1.16 Million | -2 Million | -2.08 Million | -434.12 Thousand | -639.63 Thousand | -811.45 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -359.13 Thousand | -561.9 Thousand | -328.94 Thousand | -1.39 Million | -282.33 Thousand | -121.95 Thousand |
| Depreciation & Amortization | 393.00 | 393.00 | 393.00 | 2185.00 | 546.00 | 547.00 |
| Deferred income taxes | - | - | - | -250.44 Thousand | -22.59 Thousand | - |
| Stock-based compensation | - | 239.55 Thousand | 125.06 Thousand | 234.02 Thousand | 12.21 Thousand | -27.16 Thousand |
| Change in working capital | 324.29 Thousand | 127.05 Thousand | 19.16 Thousand | 110.15 Thousand | 253.62 Thousand | 81.09 Thousand |
| Other non-cash items | 23.37 Thousand | 255.1 Thousand | 109.02 Thousand | 312.3 Thousand | 68.09 Thousand | -1.00 |
| Investing Cash Flow | -54.98 Thousand | -38.1 Thousand | -37.54 Thousand | -174.72 Thousand | -33.2 Thousand | -54.74 Thousand |
| Investments in PPE | -3.00 | -38.1 Thousand | -37.54 Thousand | -174.72 Thousand | -33.2 Thousand | -54.74 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -38.1 Thousand | -37.54 Thousand | -174.72 Thousand | - | - |
| Financing Cash Flow | 55.92 Thousand | -9189.00 | 468.28 Thousand | 1.13 Million | 3851.00 | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -5.63 | - | - | -12.50 | - |
| Common Stock Issuance | 55.92 Thousand | -9188.00 | 468.28 Thousand | 1.13 Million | 16.35 Thousand | - |
| Other Financing Activities | - | -3555.00 | -25.32 Thousand | -63.45 Thousand | -12.5 Thousand | - |
| Accounts receivables | -10.47 Thousand | -9158.00 | 18.07 Thousand | -12.05 Thousand | -9287.00 | 17.71 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 334.76 Thousand | 136.21 Thousand | 1090.00 | 122.2 Thousand | 262.91 Thousand | 63.37 Thousand |
| Cash at beginning of period | 13.16 Thousand | 249.75 Thousand | 2085.00 | 31.56 Thousand | 1882.00 | 124.1 Thousand |
| Cash at end of period | 3035.00 | 13.16 Thousand | 249.75 Thousand | 2085.00 | 2085.00 | 1882.00 |
| Capital Expenditure | -3.00 | -38.1 Thousand | -37.54 Thousand | -174.72 Thousand | -33.2 Thousand | -54.74 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -10.13 Thousand | -236.58 Thousand | 247.66 Thousand | -29.47 Thousand | 203.00 | -122.22 Thousand |
| Free Cash Flow | -11.07 Thousand | -227.39 Thousand | -220.61 Thousand | -1.16 Million | -3648.00 | -122.22 Thousand |
THACKER
MG
LLC
DODLA
SAF
SCVPF